About Candel Therapeutics, Inc. 
Candel Therapeutics, Inc.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 21 Schemes (26.59%)
Foreign Institutions
Held by 27 Foreign Institutions (2.14%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2025)
Net Profit:
-11 Million
Miscellaneous
USD 346 Million ()
NA (Loss Making)
NA
0.00%
-1.02
-48.23%
4.32






